Osteoporosis - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Osteoporosis

Description:

'Osteoporosis is a loss of bone density sufficient to cause an increased risk of fracture' ... Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose ... – PowerPoint PPT presentation

Number of Views:46
Avg rating:3.0/5.0
Slides: 23
Provided by: lucyco9
Category:

less

Transcript and Presenter's Notes

Title: Osteoporosis


1
Osteoporosis
  • Lucy Cowdrey
  • 4th November 2009

2
What is it?
3
Diagnosis
  • Osteoporosis is a loss of bone density
    sufficient to cause an increased risk of
    fracture
  • GP Notebook
  • Diagnosed when
  • -2.5 SD or below on DEXA scan
  • Can be assumed in women over 75 years

4
Why does it matter?
  • 180,000 osteoporosis-related fractures / yr in
    England and Wales
  • 70,000 hip fractures
  • 25,000 vertebral fractures
  • 41,000 wrist fractures
  • Osteoporotic fractures cost NHS 1.7 billion
    annually
  • Personal cost
  • 50 after hip unable to live independently
  • 20 die within 6 months

5
Who gets it?
  • Strongest risk factors?
  • Age
  • Female sex
  • Family history

6
Other risk factors
  • Caucasian
  • Early menopause
  • Low BMI
  • Smoking probably alcohol
  • Sedentary lifestyle
  • gt3/12 corticosteroid use
  • ?Depo-provera

7
Associated conditions
  • Anorexia
  • Chronic liver disease
  • Chronic kidney disease
  • Coeliac disease
  • Hyperparathyroidism
  • IBD
  • Rheumatoid arthritis

8
Should we test for it?
9
When to test (National Osteoporosis Guideline
Group 2008)
10
FRAX calculator
  • Assesses 10 year risk of
  • www.shef.ac.uk/FRAX
  • National Osteoporosis society also recommend
    testing if receiving steroids for gt3/12

11
General advice?
  • Stop smoking
  • Adequate calcium intake
  • Exercise

12
Should we prescribe calcium / vitamin D?
  • Dietary calcium is as effective as
    pharmacologically-derived
  • Intake of 1000mg Ca / day leads to 24 reduction
    hip
  • No evidence that Vit D required in active people
    lt65 years
  • gt65 need intake of 10µg (400IU) / day
  • Some uncertainty
  • Evidence for dose-dependent relationship
  • Always consider prescribing in housebound
    individuals
  • NICE supplementation should be considered in
    women who may be deficient

13
Here comes the science
14
Specific dietary advice?
  • 3-4 portions of the following 1000mg calcium
  • 200ml milk
  • 1 pot yoghurt
  • 30g hard cheese
  • 200g portion macaroni cheese
  • 60g sardines
  • 170g cheese tomato pizza
  • 4 slices white bread
  • 1 bowl calcium-rich cereal with milk

15
(No Transcript)
16
When should we use bisphosphonates?
  • NICE (Oct 2008)
  • Alendronate is first line
  • Use risedronate or etidronate if intolerant
  • 70 women
  • With independent risk factor
  • With indicator for low BMD
  • With confirmed osteoporosis
  • 65-69 women
  • With independent risk factor AND confirmed
    osteoporosis
  • Postmenopausal women lt65
  • With independent risk factor AND indicator for
    low BMD AND confirmed osteoporosis

17
Independent clinical risk factors (NICE)
  • Parental history of hip fracture
  • Alcohol intake of 4 units / day
  • Rheumatoid arthritis

18
Indicators of low BMD (NICE)
  • BMI lt22
  • Ankylosing spondylitis
  • Crohns disease
  • Prolonged immobility
  • Untreated menopause

19
Other drugs in primary prevention
  • Main SE bisphosphonates is oesophageal reactions
  • CI achalasia, oesophageal stricture
  • Strontium an alternative if intolerant
  • Raloxifene (SERM) not a treatment option for
    primary prevention

20
Secondary prevention
  • NICE (2008)
  • Alendronate 1st line
  • Risedronate or etidronate if intolerant
  • 2nd line strontium or raloxifene
  • 3rd line - teripatide

21
Summary
  • Consider Ca / Vit D in housebound patients or if
    poor dietary intake
  • Consider DEXA scan depending on 10yr risk
  • Consider bisphosphonates if risk factors or
    indicators for low BMD
  • Check if elderly patients have been discharged on
    bisphosphonates following

22
References!
  • Primary Prevention Ostoporosis (TA160) NICE
    October 2008
  • Secondary prevention (TA161) NICE October 2008
  • National Osteoporosis Guideline Group 2008
    Guideline for diagnosis and management
    osteoporosis
  • Management of Osteoporosis (71) SIGN 2003
  • Prevention of Nonvertebral Fractures With Oral
    Vitamin D and Dose Dependency (Arch Int Med) Mar
    2009
  • GPnotebook!
Write a Comment
User Comments (0)
About PowerShow.com